Updated Jul 16, 2026
FLATLEY JAY T has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $25K. Lifetime open-market sales: $12K. Historical track record: 3/5 stars across 4 tracked purchases.
Jay T. Flatley is a seasoned executive known for his roles in the biotechnology and automotive sectors. He has served as a director for companies such as Rivian Automotive and Denali Therapeutics, contributing his expertise in corporate governance and strategic development.
| Role | Director |
|---|---|
| Notability | 50/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★☆☆ (3/5) |
|---|---|
| Total purchases tracked | 4 |
| Purchases with forward-return data | 4 |
| 30-day win rate | 7500% |
| 90-day win rate | 7500% |
| Avg 5-day return | +132.15% |
| Avg 30-day return | +257.88% |
| Avg 90-day return | +2699.87% |
| Best 30-day return | +2013.73% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | RIVN | Rivian Automotive, Inc. / DE | A — Grant or award | 17.4K | $0.00 | |
| 2026-06-05 | DNLI | Denali Therapeutics Inc. | A — Grant or award | 6.4K | $0.00 | |
| 2026-03-05 | RIVN | Rivian Automotive, Inc. / DE | P — Open-market purchase | 1.2K | $8.84 | $11K |
| 2026-03-05 | RIVN | Rivian Automotive, Inc. / DE | S — Open-market sale | 490 | $17.07 | $8K |
| 2026-03-05 | RIVN | Rivian Automotive, Inc. / DE | P — Open-market purchase | 490 | $20.67 | $10K |
| 2026-03-05 | RIVN | Rivian Automotive, Inc. / DE | S — Open-market sale | 57 | $25.75 | $1K |
| 2026-03-05 | RIVN | Rivian Automotive, Inc. / DE | S — Open-market sale | 3 | $24.99 | $75 |
| 2026-03-05 | RIVN | Rivian Automotive, Inc. / DE | P — Open-market purchase | 60 | $26.83 | $2K |
| 2026-03-05 | RIVN | Rivian Automotive, Inc. / DE | S — Open-market sale | 30 | $62.22 | $2K |
| 2026-03-05 | RIVN | Rivian Automotive, Inc. / DE | P — Open-market purchase | 30 | $82.84 | $2K |
| 2025-06-18 | RIVN | Rivian Automotive, Inc. / DE | A — Grant or award | 16.8K | $0.00 | |
| 2025-06-03 | DNLI | Denali Therapeutics Inc. | A — Grant or award | 6.0K | $0.00 |
Jay T. Flatley is a seasoned executive known for his roles in the biotechnology and automotive sectors. He has served as a director for companies such as Rivian Automotive and Denali Therapeutics, contributing his expertise in corporate governance and strategic development.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 4 open-market purchases ($25K) and 4 open-market sales ($12K) across all tracked filings.
Across 4 tracked purchases, FLATLEY JAY T averaged +257.9% avg 30-day return with a 7500% 30-day win rate. InsiderAlpha rates the track record at 3/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live FLATLEY JAY T profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.